Centene (CNC)
(Delayed Data from NYSE)
$70.84 USD
+0.01 (0.01%)
Updated Sep 9, 2024 04:00 PM ET
After-Market: $70.82 -0.02 (-0.03%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth C Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$70.84 USD
+0.01 (0.01%)
Updated Sep 9, 2024 04:00 PM ET
After-Market: $70.82 -0.02 (-0.03%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth C Momentum A VGM
Zacks News
Centene Corporation is a well-diversified, multi-national healthcare company that primarily provides a set of services to the government sponsored healthcare programs. The company serves the under-insured and uninsured individuals through member-focused services. It is also engaged in providing education and outreach programs to inform and assist members in accessing quality, appropriate healthcare services. Centene is now a $100-billion plus enterprise catering healthcare services to more than 24 million members across 50 states. The recent acquisition of WellCare Health leveraged the company’s position as the largest Medicaid managed care organization in the country. The combined entity now has 22 million members. In 2019, the company retained its market-leading position nationwide, serving 1.8 million exchange members across 20 states at the year-end.
Molina Healthcare, Inc (MOH) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Molina (MOH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
UnitedHealth (UNH) Unit Makes Insulin More Affordable to Avail
by Zacks Equity Research
UnitedHealth Group's (UNH) sub-unit, Optum Rx, resorts to product shift within its formulary and makes the vital medication of insulin cost-effective, thereby boosting patients' access to it.
HCA Healthcare (HCA) Unveils Ambitious 5-Year Growth Targets
by Zacks Equity Research
Over the five-year horizon, HCA Healthcare (HCA) anticipates substantial 8-12% annual growth in earnings per share.
Is Centene (CNC) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Brookdale Senior (BKD) Shares Rise 1.9% Despite Q3 Earnings Miss
by Zacks Equity Research
Brookdale Senior (BKD) expects adjusted EBITDA to be within the $77-$82 million range in the fourth quarter.
Zacks.com featured highlights G-III Apparel, Titan Machinery, SM Energy, Centene and AAR
by Zacks Equity Research
G-III Apparel, Titan Machinery, SM Energy, Centene and AAR have been highlighted in this Screen of The Week article.
5 Value Stocks With Exciting EV-to-EBITDA Ratios to Own Now
by Anindya Barman
We have screened value stocks GIII, TITN, SM, CNC and AIR based on the EV-to-EBITDA ratio, which offers a clearer picture of valuation and earnings potential.
Select Medical (SEM) Stock Down 6.6% Despite Q3 Earnings Beat
by Zacks Equity Research
Select Medical (SEM) continues to expect adjusted EBITDA to be between $795 million and $825 million in 2023.
Zacks.com featured highlights Select Medical, PVH, Centene, Paysafe and HF Sinclair
by Zacks Equity Research
Select Medical, PVH, Centene, Paysafe and HF Sinclair have been highlighted in this Screen of The Week article.
Zacks.com featured highlights include Select Medical Holdings, Hibbett, PVH and Centene
by Zacks Equity Research
Select Medical Holdings, Hibbett, PVH and Centene are part of the Zacks Screen of the Week article.
5 Low Price-to-Book Stocks to Buy in November
by Kinjel Shah
The P/B ratio helps to identify low-priced stocks that have high growth prospects. Select Medical Holdings Corporation (SEM), PVH Corp. (PVH), Centene (CNC), Paysafe Limited (PSFE) and HF Sinclair Corporation (DINO) are some such stocks.
Give Your Investments a Boost With These 4 Low P/CF Stocks
by Sumit Singh
Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. Select Medical (SEM), Hibbett (HIBB), PVH Corp. (PVH) and Centene Corporation (CNC) boast low P/CF ratios.
Here's Why Centene (CNC) is a Strong Growth Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Tenet Healthcare (THC) Q3 Earnings Beat on Solid Ambulatory Care
by Zacks Equity Research
Tenet Healthcare's (THC) Q3 results gain on improved adjusted admissions and higher pricing yield. Management expects adjusted EPS of $5.43-$6.05 for 2023.
Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RSPH)?
by Zacks Equity Research
Sector ETF report for RSPH
Community Health (CYH) Stock Down 1.7% Since Q3 Earnings Release
by Zacks Equity Research
Community Health (CYH) expects net operating revenues in the range of $12,400-$12,500 million for 2023.
Should Value Investors Buy Centene (CNC) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Should SPDR Russell 1000 Low Volatility Focus ETF (ONEV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for ONEV
Molina Healthcare (MOH) Q3 Earnings Beat on Membership Growth
by Zacks Equity Research
Molina Healthcare's (MOH) third-quarter results gain from changes in the member mix and a growing premium base. Management reiterates its 2023 adjusted EPS guidance to be a minimum of $20.75.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Centene (CNC) Q3 Earnings Beat on Commercial Growth, View Raised
by Zacks Equity Research
Centene (CNC) anticipates adjusted EPS to register a minimum of $6.60 this year.
Compared to Estimates, Centene (CNC) Q3 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for Centene (CNC) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Centene (CNC) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Centene (CNC) delivered earnings and revenue surprises of 26.58% and 5.13%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Can Centene's (CNC) Q3 Earnings Beat on Membership Growth?
by Zacks Equity Research
Centene's (CNC) third-quarter results are likely to reflect higher premiums and lower cost of services.
Centene (CNC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Centene (CNC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.